FDA making it easier for compassionate use of experimental drugs. And, they're going to allow companies to CHARGE patients for the drug, if they're getting it outside of a clinical trial on a compassionate-use basis. This way the companies don't have to eat the cost of providing the drug.

http://www.fiercebiotech.com/fda-updates-expa...Q3MFpRPSJ9

I wonder how many people would like to try Kevetrin under the compassionate-use policy?